CUE - Cue Biopharma, Inc.
12.455
-5.475 -43.958%
Share volume: 695,667
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$17.93
-5.48
-0.31%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | 05-12-2025 | 08-12-2025 | 11-12-2025 | 03-16-2026 | |
| Cash flow financing | 2.354 M | -1.000 M | 9.821 M | -1.000 M | 17.798 M | 1.000 K | 9.492 M | |
| Other financing cash flows | 2.354 M | 1.000 M | 0.000 | 0.000 | 752.000 K | 1.001 M | 749.000 K | |
| Cash flow | -7.485 M | -11.000 M | 2.392 M | -9.322 M | 14.356 M | -15.791 M | 15.436 M | |
| Net income | -12.347 M | -10.171 M | -8.660 M | -12.257 M | -8.482 M | -7.448 M | 1.585 M | |
| Depreciation | 99.000 K | 99.000 K | 101.000 K | 101.000 K | 99.000 K | 80.000 K | 678.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -55.000 K | -10.000 K | 98.000 K | -150.000 K | -27.000 K | -6.768 M | 7.020 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 55.000 K | 10.000 K | -98.000 K | 150.000 K | 27.000 K | 0.000 | -20.000 K | |
| Cash Change | -7.485 M | -11.000 M | 2.392 M | -9.322 M | 14.356 M | -15.791 M | 15.436 M |